| Aug 26, 2008 |
AACR Hosts Molecular Diagnostics in Cancer Therapeutic Development Meeting
|
|
(Nanowerk News) The American Association for Cancer Research (AACR) Molecular Diagnostics in Cancer Therapeutics Development Meeting features the latest findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new biologic markers and imaging methods.
|
|
To help you take advantage of the meeting's scientific abstracts and related activities, the program schedule and related abstracts will be available online at: http://www.aacr.org on September 22, 2008. The press releases will be available to subscribing reporters on September 15 via Newswise and Eurekalert.
|
|
Nearly 100 abstracts will be presented at the meeting, complementing an outstanding program of scientific and educational events. The AACR Molecular Diagnostics in Cancer Therapeutics Meeting attracts world leaders in cancer research, including clinical oncologists, basic scientists and translational researchers.
|
|
Highlights:
|
|
Angiogenic factors that increase risk for breast cancer
Genetic markers for glioblastoma survival
New data on nanotechnology as a cost effective diagnostic method
More accurate tools for diagnosing myeloproliferative neoplasia
Late-breaking data on multispectral imaging and its utility
How the Epstein Barr virus predicts outcome in nasopharyngeal carcinoma
|
|
When: September 22-25, 2008
|
|
Where: Marriott Philadelphia Downtown, Philadelphia, PA
|
|
|
